You are performing the FINAL ASSESSMENT for Round 64 — the two mandatory prior-art attacks on the Slot 5 end-to-end candidate. The CTO must decide: does the narrow residual (forward prediction of clot fragmentation → traction-speed intervention) survive, or is it killed by prior art?

CONTEXT:
The candidate (per Round 63) is an end-to-end loop:
- SENSOR: traction-force + impedance spectroscopy + aspiration-pressure
- INFERENCE: friability index F (probability of brittle fracture under current load)
- PREDICTION: fragment escape within 30s, horizon 1-10s
- INTERVENTION: (1) halve traction speed, (2) ramp aspiration, (3) abort + reposition
- EFFECT: reduced distal embolization

The CEO's Round 63 audit identified two mandatory attacks:
1. Does US20250186070A1 teach forward PREDICTION of an imminent adverse event (not just current-state characterization)?
2. Does the prior art teach traction-VELOCITY/retrieval-SPEED modulation during thrombectomy?

============================================================
ATTACK 1 RESULTS: US20250186070A1 FULL-TEXT KEYWORD SWEEP
============================================================

I performed a full-text keyword sweep of US20250186070A1's description (the full HTML was 658K chars; the extracted description was ~15K chars; I searched the full text for prediction-related keywords).

Keywords searched (CEO's list): prediction, predict, predicted, predictive, predictor, future, forthcoming, upcoming, imminent, impending, fragment, fragmentation, fragmenting, fragments, embolization, embolize, embolic, emboli, break, breaking, broken, rupture, rupturing, failure, fail, failing, structural failure, force trajectory, trajectory of force, rate of change, derivative, gradient, slope, time series, temporal, over time, time-varying, pre-event, before failure, before fragmentation, before break, warning, alert, alarm, notification, anticipate, anticipation, anticipatory, forecast, foresee, trend, trending, threshold, exceed, cross, imminent, about to, lead time, advance, approaching, approach.

RESULTS:
- "prediction"/"predict"/"predicted"/"predictive"/"predictor": ZERO occurrences
- "future"/"forthcoming"/"upcoming"/"imminent"/"impending": ZERO occurrences
- "anticipate"/"anticipation"/"anticipatory"/"forecast"/"foresee": ZERO occurrences
- "warning"/"alert"/"alarm"/"notification": ZERO occurrences (in prediction context)
- "pre-event"/"before failure"/"before fragmentation"/"lead time": ZERO occurrences
- "fragment"/"fragments"/"fragmentation": 22 occurrences total, BUT ALL are in BACKGROUND descriptions of OTHER thrombectomy devices (rotational, rheolytic) that intentionally fragment clots. NONE describe predicting fragmentation as an adverse event.
- "fail"/"failure"/"failing": 22 occurrences, referring to (a) "failed clot removal" as a current problem in background, (b) "fail to detect a reflected signal" (sensor failure), (c) "failing to satisfy threshold conditions" (current-state classification). NONE describe predicting future failure.
- "threshold": 1 occurrence — for current-state force/pressure classification (activate/deactivate aspiration state), NOT for prediction.
- "temporal": 2 occurrences — "temporal characteristics of the signal" (current-state signal analysis), NOT temporal prediction.
- "advance"/"approach": refer to catheter advancement, not prediction.
- "trend"/"trending": ZERO occurrences.
- "rate of change"/"derivative"/"gradient"/"slope": ZERO occurrences in prediction context.

ATTACK 1 PRELIMINARY VERDICT: US20250186070A1 does NOT teach forward prediction of an imminent adverse event. Its sensor stream supports current-state characterization (clot presence, clot characteristics) and reactive aspiration-state control, NOT prediction of future fragmentation/embolization. The forward-predictive structure appears to be a genuine gap.

BUT: The CEO warned that "merely replacing 'characterize clot' with 'predict fragmentation' may be an obvious downstream application." Assess this KSR/obviousness argument honestly.

============================================================
ATTACK 2 RESULTS: TRACTION-CONTROL PRIOR ART SEARCH
============================================================

I searched 7 queries (CEO's exact terms):
1. "patent traction velocity control thrombectomy"
2. "patent retrieval speed feedback thrombectomy stroke"
3. "patent pull velocity thrombectomy automated control"
4. "patent automated retrieval speed thrombectomy force feedback"
5. "patent force-rate control thrombectomy speed modulation"
6. "patent speed modulation thrombectomy aspiration"
7. "patent traction profile optimization thrombectomy retrieval"

RESULTS: 18 patent URLs identified. Key findings:

- WO2018234887A1: "CLOSED LOOP CONTROL TECHNIQUES OF THE [motorized surgical instrument]" — teaches velocity adjustment in motorized surgical instruments (staplers, etc.), NOT thrombectomy traction.
- US4812724A: "Injector control" — dual loop controller for speed control, NOT thrombectomy.
- US9402977B2: "Catheter system" — robotic catheter system with drive assembly, general robotic catheter control, NOT thrombectomy-specific traction-speed modulation.
- US10531883B1: "Aspiration thrombectomy system" — modulates VACUUM valve and VENT valve in a cycle (vacuum pressure cycling), NOT traction/pull speed.
- Rapidpulse aspiration system: high-frequency PULSED VACUUM forces, NOT traction speed.
- WO2012114333A1: "Hybrid catheter for vascular intervention" — rotational speed of atherectomy devices, NOT linear traction.
- US10743907B2, EP3823686B1: thrombectomy devices but no traction-speed modulation teaching.
- Remaining hits: general surgical instrument motor control, NOT thrombectomy traction-speed.

ATTACK 2 PRELIMINARY VERDICT: The search did NOT find any patent that specifically teaches traction-VELOCITY (retrieval pull speed) modulation during thrombectomy based on force feedback. The prior art teaches:
- Vacuum/aspiration pressure modulation (US10531883B1, Rapidpulse)
- Motor speed control in other surgical instruments (WO2018234887A1, US4812724A)
- Robotic catheter control (US9402977B2)
- Rotational speed of atherectomy devices (WO2012114333A1)

BUT: The CEO warned that "existing thrombectomy technology already uses controlled traction/pull force, feedback and operator adjustment" and cited US11504151B2 (Stryker scraper adjusting expansion and pull force). Assess whether the actuator is truly novel or merely crowded.

============================================================
YOUR ASSESSMENT — produce these sections:
============================================================

SECTION 1: ATTACK 1 — DOES US20250186070A1 TEACH FORWARD PREDICTION?

Answer definitively:
- Does US20250186070A1 teach predicting an imminent adverse event (fragmentation, embolization) before it occurs? YES / NO / INCONCLUSIVE
- Quote the closest language (if any) that could be stretched to support prediction.
- Is the absence of prediction keywords (zero occurrences of "predict", "future", "imminent", "anticipate", "warning", "pre-event") sufficient to conclude NO?
- KSR assessment: Would it be obvious to a POSITA to add forward prediction to US20250186070A1's current-state characterization system? What would be needed (new sensor, new algorithm, new computation)?

SECTION 2: ATTACK 2 — IS TRACTION-SPEED MODULATION NOVEL?

Answer definitively:
- Does any of the 18 identified patents teach traction-VELOCITY (retrieval pull speed) modulation during thrombectomy based on force feedback? YES / NO / INCONCLUSIVE
- The CEO cited US11504151B2 (Stryker scraper with pull force monitoring/adjustment). Assess: does US11504151B2 teach traction-SPEED modulation, or only traction-FORCE monitoring/adjustment? (These are different actuators.)
- Is the distinction between "modulate aspiration pressure" (taught) and "modulate traction velocity" (potentially untaught) a genuine technical distinction or a semantic loophole (CE-012)?
- What additional search would confirm whether traction-speed modulation is truly unoccupied?

SECTION 3: THE TRUE PRIMITIVE

Per CEO directive: "The candidate survives only if: sensor stream → new predictive variable → predicts fragmentation before occurrence → specific intervention → measurable reduction in distal embolization, and that entire loop is absent from the prior-art capability landscape."

Assess:
- Is the COMPLETE LOOP absent from the prior art?
- If yes: which specific link in the loop is the "true primitive" that makes it novel?
- If no: which link is already taught, killing the loop?

SECTION 4: PRE-REGISTERED KILL CONDITIONS

The CEO specified 5 kill conditions. Assess each:
1. "No reliable pre-event signature exists" — is there evidence that a physical signature can predict fragmentation 1-10s before it occurs?
2. "Prediction lead time is too short to intervene" — is 1-10s enough time for the intervention (halve traction, ramp aspiration, abort+reposition)?
3. "Existing force/clot-sensing systems already provide equivalent warning" — does US20250186070A1 or Clotild already provide equivalent warning?
4. "Intervention is not technically executable in that window" — can traction-speed modulation + aspiration ramp + abort/reposition execute in <2s?
5. "§103 can reconstruct the complete loop" — can KSR obviousness assemble the complete loop from existing prior art?

For each: KILL CONDITION MET / NOT MET / INCONCLUSIVE

SECTION 5: FINAL VERDICT

- KILL: The narrow residual is dead. The end-to-end loop is reconstructable from prior art. Record CE-019. Slot 5 returns to EMPTY.
- CONDITIONAL SURVIVAL: The narrow residual survives at the forward-prediction primitive. State exactly what survives and what evidence is still needed.
- PROMOTE: The candidate survives as a full invention.

Do NOT make the strategic decision — the CTO decides. State the engineering case.

CONSTRAINTS:
- Be adversarial. Try to KILL the candidate.
- Do NOT use semantic distinctions as novelty loopholes (CE-012).
- Per CE-018 sharpened: the unit of novelty is the complete causal loop.
- Quote actual findings from Attacks 1 and 2.
- Mark INCONCLUSIVE where evidence is insufficient.

Target ~2000-2500 words.
